MX344268B - Proceso para purificacion de proteinas. - Google Patents

Proceso para purificacion de proteinas.

Info

Publication number
MX344268B
MX344268B MX2013004091A MX2013004091A MX344268B MX 344268 B MX344268 B MX 344268B MX 2013004091 A MX2013004091 A MX 2013004091A MX 2013004091 A MX2013004091 A MX 2013004091A MX 344268 B MX344268 B MX 344268B
Authority
MX
Mexico
Prior art keywords
proteins
purification
processes
sample
protein
Prior art date
Application number
MX2013004091A
Other languages
English (en)
Other versions
MX2013004091A (es
Inventor
K Hickman Robert
Wang Chen
Original Assignee
Abbvie Inc *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc * filed Critical Abbvie Inc *
Publication of MX2013004091A publication Critical patent/MX2013004091A/es
Publication of MX344268B publication Critical patent/MX344268B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
    • B01D15/125—Pre-filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30—Partition chromatography
    • B01D15/305—Hydrophilic interaction chromatography [HILIC]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847—Multimodal interactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Water Supply & Treatment (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

La presente invención se refiere a un método para purificar una proteína. El método involucra proporcionar una muestra conteniendo la proteína, procesar la muestra a través de una resma de cromatografía de captura, inactivar virus en la muestra y procesar a través de al menos un filtro de profundidad y membrana de intercambio iónico.
MX2013004091A 2010-10-11 2011-10-11 Proceso para purificacion de proteinas. MX344268B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39176210P 2010-10-11 2010-10-11
PCT/US2011/055691 WO2012051147A1 (en) 2010-10-11 2011-10-11 Processes for purification of proteins

Publications (2)

Publication Number Publication Date
MX2013004091A MX2013004091A (es) 2013-06-07
MX344268B true MX344268B (es) 2016-12-09

Family

ID=45938674

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004091A MX344268B (es) 2010-10-11 2011-10-11 Proceso para purificacion de proteinas.

Country Status (15)

Country Link
US (1) US20120264920A1 (es)
EP (1) EP2627425A4 (es)
JP (1) JP6023715B2 (es)
KR (1) KR20130142128A (es)
CN (1) CN103379949B (es)
AU (2) AU2011316730B2 (es)
BR (1) BR112013008738B1 (es)
CA (1) CA2813747A1 (es)
IL (1) IL225650A0 (es)
MX (1) MX344268B (es)
NZ (1) NZ608943A (es)
RU (1) RU2610667C2 (es)
SG (2) SG189872A1 (es)
TW (1) TW201221641A (es)
WO (1) WO2012051147A1 (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010141039A1 (en) * 2008-10-20 2010-12-09 Abbott Laboratories Isolation and purification of antibodies using protein a affinity chromatography
KR101847405B1 (ko) 2010-07-30 2018-04-10 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
PL2768525T3 (pl) 2011-10-18 2019-10-31 Coherus Biosciences Inc Preparaty etanerceptu stabilizowane jonami magnezu
UA116194C2 (uk) 2011-10-28 2018-02-26 Протена Біосаєнсиз Лімітед Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном
EP2773439A4 (en) * 2011-10-31 2015-07-01 Merck Sharp & Dohme CHROMATOGRAPHY METHOD FOR DECOMPOSING HETEROGENEOUS ANTIBODY AGGREGATES
KR102086061B1 (ko) 2012-01-27 2020-03-11 프로테나 바이오사이언시즈 리미티드 알파-시누클레인을 인식하는 인간화된 항체
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
TW201348247A (zh) * 2012-05-21 2013-12-01 Abbvie Inc 利用蛋白質ａ親和性層析之非人類抗體之新穎純化
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CN107188926B (zh) * 2012-06-29 2021-02-09 Emd密理博公司 在蛋白纯化过程中灭活病毒的方法
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2883272A1 (en) 2012-09-02 2014-03-06 Abbvie Inc. Methods to control protein heterogeneity
CN104902914B (zh) * 2012-09-11 2019-01-01 科荣生生物科学公司 高纯度和优异产量的正确折叠的依那西普
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
AU2013381687A1 (en) 2013-03-12 2015-09-24 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
CN104236983A (zh) * 2013-06-14 2014-12-24 中国科学院大连化学物理研究所 溶液样品中含长烷基链的离子液体的去除方法
AR096713A1 (es) * 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
US10513555B2 (en) * 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
JP2016529885A (ja) * 2013-07-12 2016-09-29 イー・エム・デイー・ミリポア・コーポレイシヨン 活性炭を使用して標的タンパク質を含む試料からのウイルス除去を決定する方法
EP3036252A1 (en) * 2013-08-21 2016-06-29 Cadila Healthcare Limited Purification process for pth
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
CA2926588C (en) 2013-10-16 2020-07-21 Oncobiologics, Inc. Buffer formulations for enhanced antibody stability
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
SG10201804200WA (en) * 2013-12-12 2018-07-30 Emd Millipore Corp Protein separations using an acrylamide containing filter
BR112016014824A2 (pt) * 2013-12-27 2017-09-19 Chugai Pharmaceutical Co Ltd Método para purificar anticorpo que tem ponto isoelétrico baixo
JP2017510452A (ja) * 2014-03-07 2017-04-13 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 生物学的生成物の分画のための装置及び方法
CA2930350C (en) * 2014-03-10 2021-04-06 Richter Gedeon Nyrt. Immunoglobulin purification using pre-cleaning steps
CN105017418B (zh) * 2014-03-27 2021-02-23 上海药明康德新药开发有限公司 单克隆抗体纯化工艺方法
WO2016036508A1 (en) 2014-09-02 2016-03-10 Emd Millipore Corporation High surface area fiber media with nano-fibrillated surface features
JP6665184B2 (ja) * 2014-12-08 2020-03-13 イー・エム・デイー・ミリポア・コーポレイシヨン 混床イオン交換吸着剤
TW202231657A (zh) * 2014-12-10 2022-08-16 以色列商歐科生物製品有限公司 製造長效ctp修飾的多肽之方法
WO2016106291A1 (en) * 2014-12-22 2016-06-30 Alexion Pharmaceuticals, Inc. Methods of purifying recombinant proteins
EP3247718B1 (en) 2015-01-21 2021-09-01 Outlook Therapeutics, Inc. Modulation of charge variants in a monoclonal antibody composition
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
WO2016207328A1 (en) * 2015-06-24 2016-12-29 Glycotope Gmbh PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES
PT3334747T (pt) * 2015-08-13 2023-12-12 Amgen Inc Formulação de gonadotrofina líquida estável
WO2017136433A1 (en) 2016-02-03 2017-08-10 Oncobiologics, Inc. Buffer formulations for enhanced antibody stability
US10416137B2 (en) * 2016-09-07 2019-09-17 Board Of Regents, University Of Texas System Electrodialytic capillary suppressor for suppressed conductometric ion chromatography
CN106749660B (zh) * 2016-12-27 2020-02-14 嘉和生物药业有限公司 单克隆抗体下游纯化过程中有效去除宿主蛋白的方法
IL312404A (en) 2017-01-30 2024-06-01 Regeneron Pharma Preparations and methods for reducing biological load in chromatography
CA3072129A1 (en) * 2017-08-30 2019-03-07 Ares Trading S.A. Method for purifying proteins
HUE057850T2 (hu) * 2017-12-21 2022-06-28 Genzyme Corp Eljárások szennyezõdések fokozott eltávolítására A fehérje kromatográfia során
CN108059650A (zh) * 2018-01-05 2018-05-22 上海药明生物技术有限公司 低pH病毒灭活工艺中的纯化方法
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
TW202003027A (zh) 2018-03-26 2020-01-16 美商百靈佳殷格翰動物保健美國有限公司 製造免疫原組合物之方法
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US10792618B2 (en) * 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
WO2020047299A1 (en) 2018-08-30 2020-03-05 HCW Biologics, Inc. Multi-chain chimeric polypeptides and uses thereof
JP7407822B2 (ja) 2018-08-30 2024-01-04 エイチシーダブリュー バイオロジックス インコーポレイテッド 単鎖キメラポリペプチドおよびその使用
CN109369776B (zh) * 2018-11-09 2020-12-25 杭州奕安济世生物药业有限公司 一种蛋白纯化系统及方法
EP4007766A1 (en) * 2019-08-01 2022-06-08 Regeneron Pharmaceuticals, Inc. Method for viral inactivation
BR112022013624A2 (pt) * 2020-01-17 2022-09-13 Regeneron Pharma Cromatografia de interação hidrofóbica para depuração viral
CN115362169A (zh) * 2020-02-11 2022-11-18 Hcw生物科技公司 色谱树脂以及其用途
CN111440226B (zh) * 2020-05-27 2022-06-03 杭州奕安济世生物药业有限公司 蛋白纯化的系统和方法
US12024545B2 (en) 2020-06-01 2024-07-02 HCW Biologics, Inc. Methods of treating aging-related disorders
JP2023544163A (ja) * 2020-10-02 2023-10-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 連続的なウイルス捕捉濾過
CN114181300A (zh) * 2021-12-20 2022-03-15 方坦思(上海)生物医药有限公司 一种高纯度单克隆抗体的制备方法
CN114409765B (zh) * 2021-12-23 2024-08-23 苏州创胜医药集团有限公司 抗体的纯化方法
CN114133446A (zh) * 2021-12-31 2022-03-04 方坦思(上海)生物医药有限公司 单克隆抗体的纯化方法
CN117736324B (zh) * 2022-09-22 2024-06-28 北京东方百泰生物科技股份有限公司 一种抗Siglec-15单克隆抗体的纯化方法
WO2024059235A2 (en) * 2022-09-16 2024-03-21 Amgen Inc. A method for harvesting products from perfusion cultures
US20240230645A9 (en) * 2022-10-21 2024-07-11 Waters Technologies Corporation Protein capture from raw cell culture using protein a affixed in open tubular and annular helically coiled tubes
WO2024096505A1 (ko) * 2022-10-31 2024-05-10 삼성바이오에피스 주식회사 친화성 크로마토그래피를 통해 불순물을 제거하는 방법

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
CA2322749A1 (en) * 1998-03-03 1999-09-10 Abgenix, Inc. Cd147 binding molecules as therapeutics
CN101333244B (zh) * 1998-05-06 2013-12-18 基因技术股份有限公司 用离子交换层析纯化蛋白质
SE9802213D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab A method for the removal/purification of serum albumins and means for use in the method
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
US6652853B2 (en) * 2001-03-08 2003-11-25 Ludwig Institute For Cancer Research Method for treating cancer using A33 specific antibodies and chemotherapeutic agents
US7189820B2 (en) * 2001-05-24 2007-03-13 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (APRIL)
WO2004022732A1 (ja) * 2002-08-30 2004-03-18 Arkray, Inc. タンパク質およびグルコース脱水素酵素の精製方法
US7777006B2 (en) * 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
KR20060033870A (ko) * 2003-06-25 2006-04-20 파멕사 에이/에스 Ｈｅｒ-2 변이체의 정제
WO2005082937A2 (en) * 2004-02-27 2005-09-09 Octapharma Ag A method of providing a purified, virus safe antibody preparation
TWI391399B (zh) * 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
AU2006329963B2 (en) * 2005-12-06 2011-06-09 Amgen Inc. Polishing steps used in multi-step protein purification processes
EP2738178A1 (en) * 2006-04-05 2014-06-04 AbbVie Biotechnology Ltd Antibody purification
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
ZA200900837B (en) * 2006-08-28 2010-05-26 Ares Trading Sa Process for the purification of FC-containing proteins
WO2008073620A2 (en) * 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
WO2008100578A2 (en) * 2007-02-14 2008-08-21 Amgen Inc. Method of isolating antibodies by precipitation
JP5999899B2 (ja) * 2008-04-08 2016-09-28 バイオ−ラッド ラボラトリーズ インコーポレーティッド 抗体のクロマトグラフィー精製法
WO2010043703A1 (en) * 2008-10-17 2010-04-22 Dsm Ip Assets B.V. Removal of host cell proteins
EP2346898A2 (en) * 2008-10-20 2011-07-27 Abbott Laboratories Antibodies that bind to il-12 and methods of purifying the same
US9109010B2 (en) * 2008-10-20 2015-08-18 Abbvie Inc. Viral inactivation during purification of antibodies cross reference to related applications
TW201030016A (en) * 2008-10-20 2010-08-16 Abbott Lab Antibodies that bind to IL-18 and methods of purifying the same
WO2010141039A1 (en) * 2008-10-20 2010-12-09 Abbott Laboratories Isolation and purification of antibodies using protein a affinity chromatography
CA2751000A1 (en) * 2009-03-11 2010-12-23 Wyeth Llc Methods of purifying small modular immunopharmaceutical proteins
GB0910591D0 (en) * 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
CN102939100A (zh) * 2009-07-21 2013-02-20 特兰斯吉恩股份有限公司 用于消化鸡胚胎的酶组合物

Also Published As

Publication number Publication date
EP2627425A4 (en) 2014-11-05
AU2011316730B2 (en) 2015-12-10
AU2016201535A1 (en) 2016-03-31
TW201221641A (en) 2012-06-01
JP6023715B2 (ja) 2016-11-09
WO2012051147A1 (en) 2012-04-19
AU2011316730A1 (en) 2013-05-02
BR112013008738B1 (pt) 2017-12-19
KR20130142128A (ko) 2013-12-27
CN103379949A (zh) 2013-10-30
CA2813747A1 (en) 2012-04-19
CN103379949B (zh) 2016-09-14
RU2610667C2 (ru) 2017-02-14
US20120264920A1 (en) 2012-10-18
MX2013004091A (es) 2013-06-07
SG10201508401TA (en) 2015-11-27
NZ608943A (en) 2015-04-24
BR112013008738A2 (pt) 2015-10-06
IL225650A0 (en) 2013-06-27
JP2013539787A (ja) 2013-10-28
SG189872A1 (en) 2013-06-28
EP2627425A1 (en) 2013-08-21
RU2013120948A (ru) 2014-11-20

Similar Documents

Publication Publication Date Title
MX344268B (es) Proceso para purificacion de proteinas.
MX354845B (es) Aparato y proceso de purificación de proteínas.
CY1118775T1 (el) Μεθοδος για την επεξεργασια νερου που χρησιμοποιειται για βιομηχανικους σκοπους
WO2012162165A3 (en) Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof
SG10201907215QA (en) Antibodies Comprising An Ion Concentration Dependent Antigen-Binding Domain, Fc Region Variants, Il-8-Binding Antibodies, And Uses Therof
WO2011136624A3 (ko) 자기장 인가부를 구비한 생물학적 시료 자동정제장치, 생물학적 시료로부터 타겟물질을 추출하는 방법, 그리고 단백질 발현 및 정제 방법
MX2013006611A (es) Tratamiento de formaciones iliticas al usar un agente quelante.
SG10201805584YA (en) ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA FcγRIIB
EP2957336A3 (en) Methods for increasing the capacity of flow-through processes
MY185177A (en) Control of gas composition of a gas separation system having membranes
MX336566B (es) Dispositivo de procesamiento de imagenes y metodo de procesamiento de imagenes.
CL2010001497A1 (es) Proceso de separacion y tratamieto de residuos por osmosis directa.
EA202090044A1 (ru) Очистка идуронат-2-сульфатазы
AU2012249274A8 (en) Neutralizing antibodies to Nipah and Hendra virus
ATE540002T1 (de) Vorrichtung zur reinigung von flüssigkeiten, insbesondere zur reinigung von ballastwasser
MA45721A (fr) Procédés de purification de protéines contenant des fragments fc
IL221609A (en) Vitamin k purification process depends on proteins such as coagulation factor ix
SG10201807572PA (en) Robust antibody purification
IL233999A0 (en) Ligands for binding antibodies and protein conjugates containing antibodies and their use in chromatography
EA201490867A1 (ru) Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения
WO2013028334A3 (en) Use of small molecules in methods for purification of biomolecules
MY181081A (en) Method for purifying antibody having low isoelectric point
EA201990593A1 (ru) Непрерывный способ для снижения гетерогенности терапевтического белка
IN2014DN10979A (es)
WO2012031137A3 (en) Vesicular stomatitis viruses

Legal Events

Date Code Title Description
FG Grant or registration